Keywords: Pharmacology, Metabolism, β-hydroxybutyrate, ketone bodies, glioma, IDH mutation, nutritional interventions, ketosis
Motivation: Exogeneous ketone body supplementation may achieve some of the health benefits of ketosis without imposing a restrictive diet and fasting.
Goal(s): To investigate the pharmacokinetics of ketone bodies in the brain after ketone monoester (KME) supplementation using high-field 1H-MRS in healthy controls and patients with IDH-mutant glioma.
Approach: Participants were measured using 7T 1H-MRS following KME ingestion to non-invasively detect and quantify ketones and cerebral metabolites over time.
Results: Ketone signals, i.e., β-hydroxybutyrate and acetone, are clearly resolved in MR spectra. β-hydroxybutyrate level increased immediately after KME-ingestion, peaking around one hour, whereas acetone levels exhibited a more gradual rise.
Impact: Ketone monoester supplementation is a complementary therapeutic strategy for many diseases, but data on ketone dynamics in the brain are limited. High-field MRS can be used to investigate pharmacokinetics of ketones in healthy tissue as well as in tumors.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords